Fact-checked by Grok 2 weeks ago

Cytochrome c

Cytochrome c is a small, globular protein essential for and , functioning primarily as a mobile electron carrier in the mitochondrial () and as a key mediator in the intrinsic pathway of . Located in the mitochondrial intermembrane space, it shuttles electrons between complex III (cytochrome bc1 complex) and complex IV (), facilitating ATP production through . Upon release into the during stress or damage signals, cytochrome c binds to Apaf-1 to assemble the , activating and initiating the cascade that executes . Structurally, cytochrome c is a highly conserved, nuclear-encoded protein of approximately 12 and 104 in mammals, featuring a single c-type group covalently attached via thioether bonds to a CXXC involving two residues. The iron is hexacoordinated by 18 (His18) as the proximal and 80 (Met80) as the distal , with the protein adopting an all-α helical fold that wraps around the , connected by flexible loops. This compact, water-soluble enables its peripheral association with the , supported by positively charged lysine residues on its surface that interact electrostatically with . In the ETC, cytochrome c's (around +260 mV) allows efficient single-electron transfer, cycling between its oxidized (Fe³⁺) and reduced (Fe²⁺) states to maintain respiratory and support supercomplex for efficient electron flow. Beyond respiration, post-translational modifications such as at residues like 58 (T58) or 97 (Y97) and nitration at 74 (Y74) modulate its activity in a tissue-specific manner, fine-tuning both electron transport efficiency and apoptotic sensitivity. During apoptosis, cytochrome c's peroxidase activity is activated upon Met80 displacement, enabling it to oxidize in the inner membrane, which promotes outer membrane permeabilization and its own release; once cytosolic, it not only drives formation but also interacts with IP3 receptors to amplify . These dual roles highlight cytochrome c's evolutionary moonlighting functions, extending to nuclear under DNA damage, underscoring its pivotal position in cellular and death pathways across species.

Structure

Overall Architecture

Cytochrome c is a compact comprising approximately 100-110 that adopts a highly conserved across eukaryotic species, characterized by a polypeptide chain wrapping around a central cofactor. The mature human form consists of 104 , while the iso-1 variant has 108, yet both maintain the core despite over 40 sequence differences. This features five α-helices—typically labeled α1 through α5 from N- to —connected by loops that stabilize the structure through hydrophobic interactions and hydrogen bonds. Distinctive omega loops, such as the central 40s loop (residues 40-57), contribute to the overall architecture by linking helical segments and accommodating the group. Key structural elements include conserved residues, such as Lys72, Lys73, Lys77, Lys86, and Lys87, positioned on the protein surface to mediate interactions with physiological partners while preserving the internal scaffold. The helices and loops form a saddle-shaped topology that cradles the , with the N- and C-terminal helices (α1 and α5) flanking the core and providing additional rigidity. This arrangement ensures evolutionary robustness, as evidenced by the near-identical three-dimensional structures of and cytochrome c. The compact fold imparts exceptional stability, with a thermal melting temperature of approximately 85°C for the equine (closely homologous to human) form under physiological conditions, reflecting strong intramolecular forces that resist unfolding. This thermal resilience, coupled with resistance to proteolysis due to the buried hydrophobic core and minimal exposed loops, allows cytochrome c to function effectively in dynamic cellular environments. Crystal structures, such as PDB 1HRC for horse cytochrome c (representative of human) and PDB 1YCC for yeast iso-1 cytochrome c at 1.23 Å resolution, confirm the fold's conservation, with root-mean-square deviations below 1 Å for aligned Cα atoms despite species-specific variations.

Heme Binding Site

The group in cytochrome c, specifically , is a derivative containing a central iron atom coordinated by four atoms in the ring. This heme is covalently attached to the protein via two thioether linkages formed between the vinyl groups at positions 2 and 4 of the heme and the sulfur atoms of residues Cys14 and Cys17 in the human sequence. These covalent bonds stabilize the heme within the , preventing its dissociation during cycling. The iron atom in heme c is axially ligated by two amino acid side chains: the imidazole nitrogen of histidine at position His18 serves as the proximal ligand, while the thioether sulfur of methionine at position Met80 acts as the distal ligand, establishing a characteristic His/Met . This ligation pattern is highly conserved across eukaryotic c and contributes to the specificity of by modulating the electronic properties of the iron center. The heme is nestled in a hydrophobic pocket formed by the α-helical fold of the protein, which shields it from solvent exposure. The thioether bonds are formed post-translationally through a maturation process involving the addition of the to the apoprotein, where the vinyl groups of the undergo nucleophilic attack by the groups of Cys14 and Cys17, resulting in stable C-S linkages without altering the . This covalent attachment enhances the of the Fe(III)/Fe(II) to approximately +260 versus the , a value tuned by the axial ligands, the hydrophobic environment of the crevice, and limited solvent access that stabilizes the state relative to the ferric one. Variations in this potential across arise from subtle differences in the pocket, but the human value exemplifies the optimal tuning for mitochondrial electron transport.

Surface Properties

Cytochrome c exhibits a highly asymmetric charge distribution on its surface, resulting in a strong positive of approximately 300 . This arises primarily from the uneven placement of positively charged residues, particularly lysines, which cluster on one side of the protein while negative residues are more dispersed. The of this facilitates the protein's approach to negatively charged binding partners, such as and reductase, by aligning the positive pole toward these sites during complexes. The surface of cytochrome c is dominated by approximately 16-20 residues in mammalian variants, forming a positively charged belt encircling the edge. This belt, comprising residues such as Lys13, Lys27, Lys72, Lys73, Lys86, and Lys87, among others, creates a ring of positive charges that promotes electrostatic interactions with acidic surfaces on partner proteins and phospholipids. In horse heart cytochrome c, a well-studied model, there are 19 surface-exposed residues contributing to this overall positive character, enhancing and enabling transient docking without permanent occlusion of the crevice. The (pI) of cytochrome c is around 10, reflecting its basic nature due to this lysine-rich exterior, which ensures the protein remains positively charged and soluble at physiological values near 7.43247-X/pdf) In addition to its electrostatic features, cytochrome c possesses limited hydrophobic patches on its surface, primarily involving exposed nonpolar residues like Phe10, Tyr67, and Trp59 near the periphery. These patches allow weak, reversible association with mitochondrial membranes, particularly during translocation events such as release from the , where partial unfolding may enhance hydrophobic contacts with cardiolipin-rich bilayers. This balanced hydrophobicity prevents aggregation in the aqueous while permitting membrane interactions under specific conditions.

Distribution and Evolution

Occurrence Across Species

Cytochrome c is a highly conserved protein that is ubiquitous in the mitochondria of eukaryotic organisms, including , , and fungi, where it plays essential roles in . In mammals, such as humans and mice, it exists as and testis-specific isoforms with high sequence identity, reflecting its evolutionary stability across these kingdoms. However, it is absent in the modified mitochondria (mitochondrion-related organelles) of certain anaerobic eukaryotes, such as some protists, which lack components of the oxidative including . In prokaryotes, functional analogs of cytochrome c are present, particularly in where they serve as electron carriers in respiratory or photosynthetic chains. These bacterial c are typically localized in the or associated with the cytoplasmic membrane; for example, in the purple photosynthetic bacterium Rhodobacter capsulatus, cytochrome c' is a periplasmic protein involved in . Within eukaryotic mitochondria, cytochrome c is strictly localized to the , where it is loosely associated with the inner membrane, often bound to (15-20% of total cytochrome c). It is nuclear-encoded and synthesized in the as apocytochrome c, lacking a cleavable N-terminal presequence but utilizing internal targeting elements and the translocase complex for import into the , followed by covalent attachment. In mammalian mitochondria, cytochrome c constitutes a significant portion of total mitochondrial protein by mass, underscoring its abundance and central role in .

Sequence and Structural Variants

Cytochrome c exhibits considerable sequence diversity across while maintaining key structural elements essential for its function. In vertebrates, the protein typically comprises 103-108 residues, with mammalian forms often at 104 or 105 residues. A hallmark of this diversity is the presence of highly conserved motifs, such as the CXXCH , where the two cysteines form thioether bonds with the group, and the serves as an axial to the heme iron. This motif is invariant across eukaryotic cytochrome c variants, ensuring proper heme incorporation and activity. Mammals express distinct isoforms of cytochrome c to meet tissue-specific demands. The human CYCS primarily encodes the somatic isoform, a 105-residue protein ubiquitously expressed in mitochondrial electron transport. In contrast, a testis-specific isoform, encoded by a duplicated (CYCT in ), predominates in male cells of many mammals and features subtle sequence differences, such as a threonine-to-isoleucine at position 58, which enhances stability and activity. This isoform arises from an ancient duplication event approximately 150 million years ago but has been lost in ; in humans, it exists as a non-transcribed , and the somatic isoform fulfills functions in both somatic tissues and cells. Evolutionarily, cytochrome c displays remarkable , reflecting its ancient origins in the bacterial ancestor of mitochondria. The mitochondrial form diverged from bacterial cytochrome c2 through endosymbiosis, with subsequent adaptations in eukaryotes leading to distinct maturation systems. For instance, human cytochrome c shares approximately 45% sequence identity with iso-1-cytochrome c, despite over a billion years of divergence, underscoring the preservation of core folds like alpha-helices and heme-binding regions. This conservation highlights hotspots of stability in helices A through E, which resist variation to maintain structural integrity. Recent bioinformatics analyses of over 1,000 cytochrome c from diverse eukaryotes have reinforced these patterns, identifying stability hotspots primarily in the N-terminal helices A-E and the heme crevice loop. These regions show minimal variability, with rarely disrupting folding, while peripheral loops tolerate more . Such studies, leveraging structural predictions and evolutionary alignments, reveal how sequence variants cluster in non-conserved areas without compromising overall .

Core Functions in Mitochondria

Electron Transport Role

Cytochrome c functions as a soluble, mobile electron carrier within the mitochondrial (ETC), positioned between complex III (cytochrome bc₁ complex) and complex IV (, CcO). It receives electrons from the reduced generated at complex III and transfers them to CcO, contributing to the proton gradient essential for ATP synthesis. The mechanism involves diffusion of cytochrome c in the intermembrane space, with transient electrostatic binding to its redox partners facilitated by positively charged lysine residues on cytochrome c interacting with negatively charged surfaces on complex III and CcO. Reduction occurs upon docking with the bc₁ complex, converting the heme iron from Fe³⁺ to Fe²⁺, followed by dissociation and diffusion to CcO for oxidation back to Fe³⁺. The heme group acts as the central redox site for these transfers. Electron shuttling is optimized at physiological ionic strengths, where diffusion and collision rates match the demands of respiratory flux.60707-0/pdf) Kinetically, cytochrome c exhibits a diffusion coefficient of approximately $10^{-7} cm²/s in , supporting efficient mobility despite its association with the inner . The intrinsic electron transfer rates to and from its partners reach ~$10^6 s⁻¹, enabling high turnover without rate-limiting bottlenecks in the . At , the overall reaction consumes four reduced cytochrome c molecules per oxygen reduced: $4\ \ce{cyt\ c\ (Fe^{2+})} + \ce{O2} + 4\ce{H+} \rightarrow 4\ \ce{cyt\ c\ (Fe^{3+})} + 2\ce{H2O} This step integrates electron flow with proton translocation for energy conservation.

Peroxidase and Antioxidative Activity

Cytochrome c exhibits peroxidase activity primarily in its detached or released state from the inner mitochondrial membrane, where it can bind hydrogen peroxide (H₂O₂) and cardiolipin (CL), leading to the oxidation of lipids or self-oxidation. In this conformation, the protein acts as a catalyst for H₂O₂-dependent oxidation reactions, forming reactive intermediates such as Compound I and II that facilitate electron transfer to substrates like CL. This activity is notably enhanced upon interaction with mitochondrial membranes, allowing cytochrome c to contribute to lipid peroxidation under oxidative stress conditions. The binding of cytochrome c to anionic lipids like induces a conformational change that activates its mode by disrupting the native axial ligation of the iron. Specifically, the interaction with displaces the Met80 ligand, replacing it with a non-native His/His coordination (involving His26 or His33), which opens the crevice and increases accessibility for H₂O₂ binding. This structural transition, driven by electrostatic interactions at residues (e.g., Lys72, Lys73) and hydrophobic contacts, boosts activity by up to 100- to 1,000-fold compared to the native state, enabling selective oxidation of polyunsaturated to hydroperoxy derivatives. As part of its antioxidative role, cytochrome c reduces (O₂⁻) to H₂O₂, thereby preventing propagation of oxidative chain reactions in the mitochondrial . This superoxide dismutase-like activity proceeds via the reduction of ferricytochrome c by O₂⁻ (with a second-order rate constant of approximately 1.1 × 10⁶ M⁻¹ s⁻¹ at pH 7.2), followed by reoxidation that yields H₂O₂. Additionally, cytochrome c scavenges H₂O₂ through its function, with a bimolecular rate constant of about 1.3 × 10⁴ M⁻¹ s⁻¹ for the reaction with reduced cytochrome c, mitigating further (ROS) formation. In physiological contexts such as ischemia or (ETC) overload, cytochrome c's and antioxidative activities protect mitochondria from excessive ROS accumulation. During ischemic conditions, where ETC dysfunction elevates ROS levels, the protein's ability to detoxify O₂⁻ and H₂O₂ helps preserve membrane integrity and limit oxidative damage to lipids and proteins. Similarly, under ETC overload, cytochrome c buffers generated at complexes I and III, reducing the risk of peroxidation cascades that could impair mitochondrial function.

Role in Apoptosis

Mitochondrial Release

The release of cytochrome c from mitochondria is a pivotal event in the intrinsic pathway of apoptosis, involving the permeabilization of the outer mitochondrial membrane to allow translocation of the protein from the intermembrane space to the cytosol. This process is primarily triggered by the activation of pro-apoptotic Bcl-2 family members, Bax and Bak, which oligomerize to form large pores in the outer membrane, enabling the efflux of intermembrane space proteins including cytochrome c. The voltage-dependent anion channel (VDAC) in the outer membrane can also open in response to apoptotic stimuli, facilitating cytochrome c passage either directly or in coordination with Bax/Bak pores. Additionally, peroxidation of cardiolipin, a key inner membrane phospholipid, promotes cytochrome c detachment from the inner membrane; this oxidation is catalyzed by the peroxidase activity of cytochrome c itself under stress conditions. The translocation process occurs through these outer membrane pores, with cytochrome c diffusing into the to engage downstream effectors. Studies indicate that partial release of cytochrome c is sufficient to initiate , as a threshold level—rather than complete depletion from mitochondria—activates the necessary biochemical cascades without fully compromising . This selective release ensures that apoptosis can proceed while initially preserving some mitochondrial function. Upon exposure to apoptotic stimuli such as DNA damage or cytokines like TNFα, cytochrome c is rapid, often completing within minutes to an hour depending on the intensity of the signal. Recent structural investigations have revealed that oxidation of cytochrome c enhances its propensity to form aggregates, which may further facilitate detachment from and passage through outer membrane pores during the release process.

Apoptosome Activation

Upon translocation to the , cytochrome c interacts with the apoptotic protease activating factor 1 (Apaf-1) and (dATP) to initiate assembly. This binding induces a conformational change in Apaf-1, releasing its autoinhibitory state and promoting nucleotide exchange from ADP to dATP, which drives the oligomerization of multiple Apaf-1 monomers into a large, wheel-like heptameric complex approximately 700 kDa in molecular weight. The resulting apoptosome features a central hub formed by the nucleotide-binding oligomerization domains of seven Apaf-1 subunits, with each unit associated with a cytochrome c molecule at the periphery and the caspase recruitment domains (CARDs) exposed on the surface for further interactions. Cytochrome c specifically binds to the WD40 repeat domains of Apaf-1, facilitating the CARD oligomerization that stabilizes the complex. This structure, resolved at near-atomic resolution, reveals a symmetric ring approximately 20 nm in diameter, enabling efficient platform formation. Recent in-cell imaging studies (as of October 2025) indicate that in living cells, the apoptosome manifests as dynamic, pleiomorphic assemblies of Apaf-1 forming transient cytoplasmic foci, rather than discrete heptameric wheels observed in vitro; these higher-order structures depend on Bax/Bak-mediated cytochrome c release and recruit caspase-9 via CARD interactions. The apoptosome recruits procaspase-9 via homotypic CARD-CARD interactions, positioning multiple procaspase-9 molecules in close proximity to induce their dimerization and autoactivation into mature caspase-9. Activated caspase-9 subsequently proteolytically processes effector caspases, such as caspase-3 and caspase-7, triggering a cascading amplification of the apoptotic signal that commits the cell to death within hours. This mechanism ensures robust signal transduction from low levels of released cytochrome c, with each apoptosome capable of activating dozens of caspase molecules to dismantle cellular structures systematically.

Regulatory Inhibition

Cellular mechanisms tightly regulate cytochrome c's pro-apoptotic function to prevent inappropriate , involving both pre-release sequestration and post-release inhibition. Members of the , such as and , act as key anti-apoptotic proteins that maintain cytochrome c within mitochondria by binding to pro-apoptotic effectors like Bax and Bak, thereby blocking the formation of mitochondrial outer membrane pores and inhibiting cytochrome c release. Overexpression of these proteins is a common mechanism in cancer cells to evade . Following cytochrome c release and apoptosome formation, inhibitors of apoptosis proteins (IAPs) provide additional checkpoints by directly binding and suppressing downstream . X-linked IAP (XIAP) potently inhibits executioner -3 and -7 through its baculovirus IAP repeat (BIR) domains, preventing proteolytic cleavage of cellular substrates essential for execution. Similarly, , another IAP family member, associates with the to inhibit activation and suppress -3 processing, thereby dampening the apoptotic signal. Heat shock proteins offer a feedback mechanism; for instance, HSP27 binds directly to released cytochrome c in the , sequestering it and preventing its interaction with Apaf-1 to inhibit assembly and activation. A critical aspect of regulation involves thresholds for cytochrome c release, where partial or sublethal mitochondrial outer membrane permeabilization (MOMP) allows limited cytochrome c efflux that can be scavenged by cellular buffers without triggering full apoptotic signaling. This phenomenon contributes to cancer resistance, as sublethal cytochrome c release in residual tumor cells activates adaptive pathways like ATF4-mediated stress responses, promoting drug-tolerant persister states and therapy evasion. Evolutionary adaptations enhance regulatory inhibition in long-lived cells, such as neurons and cardiomyocytes, through tissue-specific expression of anti-apoptotic factors that modulate cytochrome c-dependent . For example, heightened levels of proteins and IAPs in post-mitotic provide robust protection against aberrant , ensuring integrity over extended lifespans while maintaining responsiveness to pathological stresses. This tissue-specific tuning reflects conserved mechanisms balancing and programmed death across species.

Extramitochondrial Functions

Cytoplasmic Localization

Under normal physiological conditions, a small fraction of cytochrome c, typically less than 5% of the total cellular pool, is present in the due to low-level basal leakage from mitochondria. This non-apoptotic release maintains cytosolic without triggering pathways. This basal leakage enables cytochrome c to act as a scavenger of (ROS) in the , mitigating by reducing and other peroxides. In extramitochondrial contexts, cytochrome c exhibits activity against peroxides, contributing to antioxidative defense. Under hypoxic conditions, cytosolic cytochrome c supports alternative electron transfer processes, facilitating adaptation to low oxygen environments by donating electrons to non-mitochondrial acceptors. Additionally, in the , cytochrome c binds to heat shock proteins (HSPs) such as Hsp27, which exert chaperone activity to stabilize it and prevent aggregation during stress. Recent 2025 studies highlight cytochrome c's moonlighting roles in the cytosolic stress response, including repression of ferroptosis through interactions that modulate iron-dependent lipid peroxidation. These functions underscore its adaptive significance beyond mitochondrial confines.

Nuclear and Moonlighting Roles

Cytochrome c (Cyt c) translocates to the nucleus primarily in response to DNA damage or oxidative stress, independent of caspase activation during apoptosis. Although it lacks a classical nuclear localization signal (NLS), this import likely occurs through mechanisms involving nucleoporins such as Nup107 or pathways akin to those used by Apaf-1, facilitating entry across the nuclear pore complex. Once in the nucleus, Cyt c binds directly to histones and histone chaperones, including SET/TAF-Iβ, NRP1, ANP32B, and nucleolin, via electrostatic interactions between its lysine-rich regions and the acidic domains of these chaperones. This binding competitively inhibits histone chaperone activity, stalling assembly and disassembly to promote relaxation at damage sites, thereby enhancing accessibility for factors. In addition, Cyt c undergoes liquid-liquid (LLPS) with SET/TAF-Iβ and nucleophosmin (NPM1), forming biomolecular condensates at DNA damage foci and nucleoli; these structures recruit protein 1α (HP1α) and modulate . By fine-tuning dynamics, nuclear Cyt c regulates transcription and processes, switching from a pro-survival role in mild damage (delaying reassembly for repair) to a pro-death function if damage persists. Beyond its electron transport role, Cyt c exhibits functions in the , including direct DNA binding that supports repair and transcriptional regulation under stress. Recent 2024 studies highlight its phase separation-driven recruitment of nuclear partners to , influencing by altering turnover. Furthermore, Cyt c-like domains have been identified in the human large-conductance calcium- and voltage-activated (BK) channel, specifically a heme regulatory motif (⁶¹²CKACH⁶¹⁶) in the RCK1-RCK2 linker that confers activity with high H₂O₂ affinity, suggesting evolutionary extensions for regulation under oxidative conditions. In prokaryotes, bacterial cytochrome c homologs display parallel stress-response functions, such as activity to scavenge (ROS) and protect DNA integrity, mirroring eukaryotic roles in oxidative without a distinct . Pathologically, elevated levels of Cyt c occur in neurodegenerative disorders like , where mitochondrial dysfunction in affected neurons leads to increased Cyt c levels and , indicating cellular degeneration.

Regulation and Modifications

Post-Translational Changes

Cytochrome c undergoes several post-translational modifications (PTMs) beyond that influence its stability, localization, and function within the mitochondria. These covalent alterations, including , ubiquitination, nitrosylation, and glycation, respond to cellular conditions such as and metabolic changes, helping to fine-tune (ETC) efficiency and protein turnover. Acetylation of cytochrome c occurs primarily at the and on residues, serving to block proteolytic and modulate electrostatic interactions. N-terminal , a co-translational process catalyzed by N-acetyltransferases, protects the apoprotein form of cytochrome c from ubiquitin-dependent , thereby enhancing its overall during mitochondrial and . Additionally, , such as at position K39, neutralizes positive charges on the protein surface, which alters its binding affinity to in the inner mitochondrial membrane and influences localization between the and cristae. This modification has been observed in tissue-specific contexts, where it stabilizes the protein against oxidative damage. Ubiquitination targets cytochrome c for proteasomal , playing a in regulating its turnover, particularly for the apo-form or upon mitochondrial release. In models, the apo-iso-1 variant of cytochrome c is ubiquitinated when into mitochondria fails, leading to rapid cytosolic via the 26S to prevent aggregation or aberrant signaling. In mammalian cells, the E3 ubiquitin PARC (p53-associated parkin-like cytoplasmic protein)/CUL9 mediates ubiquitination of released cytochrome c, facilitating its clearance and maintaining mitochondrial by controlling protein levels post-stress. S-nitrosylation involves the addition of a group to form S-nitrosothiols, which occurs on cytochrome c during oxidative or nitrosative stress to modulate its activity. Although mammalian cytochrome c lacks free cysteines due to covalent attachments at Cys14 and Cys17, nitrosylation can target nearby reactive sites or occur transiently on the heme iron, inhibiting and protecting against excessive (ROS) production in the . This modification is reversible and serves as a switch, with denitrosylation by systems restoring function under resolving stress conditions. Glycation, a non-enzymatic modification by glucose or reactive carbonyls, accumulates on cytochrome c in hyperglycemic states like , impairing its role in the . Advanced end products (AGEs) form on and residues, altering the protein's structure and reducing its ability to shuttle electrons between complexes III and IV, which contributes to mitochondrial dysfunction and diminished ATP synthesis. In diabetic models, glycated cytochrome c exhibits decreased oxidase activity and increased susceptibility to , exacerbating energy deficits in affected tissues.

Phosphorylation Effects

Phosphorylation of cytochrome c occurs primarily at specific and serine/ residues, including Tyr97 (Y97), Tyr67 (Y67), Thr58 (T58), Thr28 (T28), and Ser47 (S47), with tissue-specific patterns such as Y97 in heart and brain, Y67 in bovine heart, T58 in liver, and T28 in kidney. These modifications dynamically regulate the protein's electron shuttling in the mitochondrial (ETC) and its pro-apoptotic functions. Phosphorylation at Y97, first identified in bovine heart mitochondria, reduces cytochrome c's affinity for (CcO), the terminal complex, thereby slowing rates by up to 50% and decreasing overall oxygen consumption while maintaining a healthy mitochondrial . This site-specific change also enhances the protein's intrinsic activity, which supports oxidation during , but under normal conditions, it limits excessive respiration to prevent mitochondrial hyperpolarization and (ROS) overproduction. In cardiac cells, Y97 confers protection against by fine-tuning flux and restraining apoptotic signaling. Likewise, Y67 , mapped in bovine heart cytochrome c via , impairs binding to both CcO and , reducing respiratory complex activities and oxygen consumption rates in isolated mitochondria and permeabilized cardiomyocytes. This modification increases cytochrome c's release propensity from the , yet it paradoxically inhibits caspase-3 activation and oxidative stress-induced , promoting survival in cardiac contexts. A 2025 study demonstrated that Y67 controls flux by disrupting long-range electron transport, highlighting its role in cardioprotection. Serine/threonine phosphorylations exert comparable inhibitory effects on respiration; for instance, T58 phosphorylation in liver cytochrome c decreases interaction and by approximately 30%, while also diminishing the protein's capacity to trigger assembly and activation. T28 phosphorylation in tissue stabilizes the protein but similarly curtails efficiency, preventing pathologically high respiration that could lead to ROS accumulation. S47 phosphorylation further modulates these dynamics by restricting hyper-respiration under stress. The kinases mediating these phosphorylations are not fully identified, though stress-responsive pathways involving (PKC) and (PKA) contribute to their regulation during oxidative or ischemic challenges. Dephosphorylation by mitochondrial phosphatases, such as protein phosphatase 2A, reverses these effects to restore respiratory function. Overall, phosphorylation balances cytochrome c's roles in efficient ATP production versus controlled , with disruptions—such as mutations at these sites—impairing this equilibrium and linking to exacerbated mitochondrial dysfunction in ischemia.

Applications and Biomedical Relevance

Experimental and Diagnostic Uses

Cytochrome c holds historical significance in protein biochemistry as one of the earliest proteins to have its complete sequence determined, with the sequence of horse heart cytochrome c elucidated in 1961 through peptide mapping and techniques. This milestone, achieved by Margoliash et al., provided foundational insights into protein evolution and structure-function relationships, as cytochrome c sequences from various species revealed conserved residues critical for binding and . Additionally, in the mid-20th century, purified cytochrome c served as a standard in titrations to measure midpoint potentials of biological electron carriers, leveraging its well-defined +0.26 V potential versus the for calibrating electrochemical systems in mitochondrial studies. A prominent experimental application of cytochrome c is in the quantification of anion (O₂⁻) through the ferricytochrome c , a spectrophotometric that monitors the of ferricyt c (cyt c³⁺) to ferrousyt c (cyt c²⁺) by O₂⁻, resulting in a measurable increase in absorbance at 550 nm (ΔA₅₅₀). This , originally developed for detecting extracellular from and enzymes like , calculates O₂⁻ concentration using the difference of 21 mM⁻¹ cm⁻¹ between oxidized and reduced forms, with specificity enhanced by () inhibition of the signal. The technique remains widely used in cell-free systems and formats for assessing (ROS) production in biochemical and pharmacological research. In enzymatic studies, cytochrome c acts as a model due to its ability to catalyze peroxide-dependent oxidation of substrates like tetramethylbenzidine, mimicking peroxidases through transient Compound I-like intermediates formed upon H₂O₂ binding to its iron. This activity, activated by partial unfolding or covalent modifications, has been exploited to investigate mechanisms and responses. For development, cytochrome c is immobilized on surfaces via methods such as layer-by-layer , covalent attachment to like carbon nanotubes, or entrapment in polymers, enabling sensitive electrochemical detection of analytes including H₂O₂, , and with detection limits in the nanomolar range. These immobilized constructs retain efficiency and stability, facilitating applications in portable diagnostic devices for oxidative biomarkers. Protein engineering efforts have generated cytochrome c mutants to dissect electron transfer pathways, with site-directed substitutions at surface lysines or heme crevices altering docking interfaces and kinetics in complexes with partners like , as demonstrated in stopped-flow studies revealing rate enhancements or inhibitions up to 100-fold. For instance, iso-1-cytochrome c variants with or mutations at position 82 modulate interprotein rates, providing quantitative models for predictions. Furthermore, wild-type and mutant cytochrome c serve as benchmarks in , with horse heart cytochrome c's high-resolution NMR and crystal structures (resolved to 1.5 Å) establishing standards for validating folding dynamics, orientation, and paramagnetic shift assignments in studies.

Therapeutic and Disease Associations

Mutations in the CYCS gene, which encodes cytochrome c, are associated with thrombocytopenia-4 (THC4), an autosomal dominant disorder characterized by isolated thrombocytopenia without other syndromic features. Pathogenic variants, such as G41S and Y48H, impair the protein's apoptotic function while preserving its role in electron transport, leading to reduced platelet production due to decreased apoptosis in megakaryocytes. These mutations highlight cytochrome c's dual role in hematopoiesis and underscore the potential for targeted genetic interventions to restore normal platelet levels. In neurodegenerative diseases, aberrant release of cytochrome c from mitochondria contributes to neuronal and via (ROS) generation. In , mitochondrial dysfunction promotes cytochrome c translocation to the , exacerbating dopaminergic loss through activation. Similarly, in , impaired activity and subsequent ROS accumulation facilitate cytochrome c release, driving amyloid-beta-induced neuronal death. In cancer, overexpression of anti-apoptotic proteins such as inhibits cytochrome c release, thereby promoting tumor cell survival and resistance to . Conversely, therapeutic strategies exploiting cytochrome c include the of analogs and systems, such as nanoparticle-encapsulated cytochrome c conjugated with cell-penetrating peptides, to induce targeted in cancer cells. A 2025 advance involves small-molecule inhibitors of OPA1 that amplify cytochrome c release, sensitizing cells to Bcl-2 inhibitors and improving outcomes in preclinical models. Serum levels of cytochrome c serve as a for in cardiovascular diseases, particularly acute (AMI). Elevated circulating cytochrome c correlates with impaired myocardial reperfusion in ST-elevation (STEMI) patients undergoing , reflecting mitochondrial damage and apoptotic cardiomyocyte loss. Prognostic studies indicate that higher cytochrome c concentrations predict increased in-hospital mortality post-AMI, aiding in stratification.

References

  1. [1]
    Regulation of Respiration and Apoptosis by Cytochrome c ... - Nature
    Nov 1, 2019 · Cytochrome c (Cytc) is a multifunctional protein, acting as an electron carrier in the electron transport chain (ETC), where it shuttles ...
  2. [2]
    New moonlighting functions of mitochondrial cytochrome c in the ...
    Oct 29, 2019 · However, Cc has moonlighting roles outside mitochondria driving the transition of apoptotic cells from life to death.
  3. [3]
    Structure of a mitochondrial cytochrome c conformer competent for ...
    Apr 23, 2014 · Cytochrome c is essential to two important biochemical pathways, the electron transport chain and the intrinsic pathway of apoptosis.
  4. [4]
    Cytochrome C - an overview | ScienceDirect Topics
    Cytochrome c is functionally involved in the electron transport chain of mitochondria. That electron transport is part of the pathway for synthesis of ATP.<|control11|><|separator|>
  5. [5]
    The role of key residues in structure, function, and stability of ... - NIH
    Structure analysis suggests that the tertiary structure of cyt-c is almost preserved along the evolutionary scale. Furthermore, residues of N/C-terminal helices ...
  6. [6]
    A computational study of the fold and stability of cytochrome c with ...
    The protein fold comprises five α-helices connected by three so-called for historic reasons Ω-loop regions, namely distal (residues 72–86), central (residues 41 ...
  7. [7]
    A comprehensive guide through the fold and stability of cytochrome ...
    Jul 24, 2024 · The protein fold comprises five α-helices connected by three so-called for historic reasons Ω-loop regions, namely distal (residues 72-86), ...
  8. [8]
    Joule heating and thermal denaturation of proteins in nano-ESI theta ...
    Similar phenomena were noted with equine cytochrome c (eCyt c), which has a reported melting temperature of 85 °C. [52] This protein contains a covalently ...
  9. [9]
  10. [10]
  11. [11]
  12. [12]
    The multiple functions of cytochrome c and their regulation in life ...
    ... iron ligands His18 and Met80 was proposed to explain the high redox potential of Cytc of about 260 mV in mammals (Salemme, 1977). Of the entire heme surface ...
  13. [13]
    The dipole moment of cytochrome c - PubMed
    Vertebrate cytochromes c and the cytochromes c of insects and plants have, on average, dipole moments of 320 and 340 debye, respectively.
  14. [14]
    Supramolecular Chemistry Targeting Proteins - ACS Publications
    ... positively charged belt close to the heme edge of cytochrome c (cyt-c). As a result, the binding of cyt-c to its natural protein partner, cytochrome c ...
  15. [15]
    Cytochrome c adsorption on carboxylated surfaces - RSC Publishing
    Sep 16, 2025 · We quantify how curvature, pH, and salt concentration regulate cytC adsorption to carboxyl-terminated polymer brushes using molecular theory ...Missing: patches | Show results with:patches
  16. [16]
    Cytochrome c impaled: investigation of the extended lipid ... - NIH
    The electrostatic association was sensitive to ionic strength, polyanions and pH, whereas the hydrophobic interactions were enhanced by conformational changes ...
  17. [17]
    Investigation of the Molecular Mechanisms of the Eukaryotic ... - NIH
    Apr 7, 2022 · Cytochromes-c are ubiquitous heme proteins with enormous impact ... eukaryotic cytochrome c in Escherichia coli. J. Biol. Inorg. Chem ...
  18. [18]
    Cytochrome c as a biocatalyst - ScienceDirect.com
    Cytochrome c is a protein ubiquitous to all eukaryotic organisms and the ... Comparison of these sequences shows that cytochromes c in eukaryotic organisms are ...
  19. [19]
    Biochemistry and Evolution of Anaerobic Energy Metabolism in ...
    They lack cytochromes, a membrane-associated electron transport chain, and a genome. They produce ATP exclusively via substrate-level phosphorylation.
  20. [20]
    Bacterial cytochromes c biogenesis - Genes & Development
    These cytochromes function as electron transfer proteins and differ from other cytochromes in that their heme is attached covalently (Pettigrew and. Moore 1987) ...
  21. [21]
    Cytochrome c′ from Rhodobacter capsulatus Confers Increased ...
    We report the cloning and sequencing of the gene containing cytochrome c′ (cycP) from the photosynthetic purple bacterium Rhodobacter capsulatus and the regions ...Missing: analogs prokaryotes
  22. [22]
    Mechanisms of cytochrome c release from mitochondria - Nature
    May 5, 2006 · In healthy cells, cytochrome c (Cyt c) is located in the mitochondrial intermembrane/intercristae spaces, where it functions as an electron ...
  23. [23]
    Import of apocytochrome c into the mitochondrial intermembrane ...
    The precursor protein, apocytochrome c, does not contain a cleavable presequence ... In summary, cyt2-1 mitochondria contained little or no cytochrome c heme ...
  24. [24]
    Apocytochrome c requires the TOM complex for translocation across ...
    In this investigation, we have reconstituted the import of apocytochrome c into the mitochondrial intermembrane space using proteoliposomes containing purified ...
  25. [25]
    Protein Machineries Involved in the Attachment of Heme to ...
    Dec 23, 2013 · Despite that in all c-type cytochromes, both prokaryotic or eukaryotic, the heme is always covalently linked to the conserved CXXCH heme-binding ...
  26. [26]
    54205 - Gene ResultCYCS cytochrome c, somatic [ (human)] - NCBI
    Aug 19, 2025 · This work reveals a direct conformational link between the 40-57 Omega-loop of cytochrome c in which residue 41 resides and the dynamical ...
  27. [27]
    Remarkably high activities of testicular cytochrome c in ... - PNAS
    Jun 13, 2006 · During the development of male mammalian germ cells, a testis-specific form of Cc (T-Cc) that differs from its counterpart in somatic cells (S-C ...
  28. [28]
    CYCS - Cytochrome c - Homo sapiens (Human) | UniProtKB | UniProt
    Jan 23, 2007 · P99999 · CYC_HUMAN. Protein. Cytochrome c. Gene. CYCS. Status. UniProtKB reviewed (Swiss-Prot). Organism. Homo sapiens (Human). Amino acids. 105 ...
  29. [29]
    Evolution of mitochondrial-type cytochrome c domains and of the ...
    It is found that the first appearance of mitochondrial-type cytochrome c domains has likely happened in the bacterial world, together with the first apparatus ...
  30. [30]
    Cytochrome c phosphorylation: Control of mitochondrial electron ...
    Feb 2, 2020 · Cytc is an electron carrier in the mitochondrial electron transport chain (ETC) and thus central for aerobic energy production. Under conditions ...
  31. [31]
    Complex structure of cytochrome c–cytochrome c oxidase reveals a ...
    Dec 15, 2016 · A 2.0‐Å X‐ray structure of the cytochrome c–CcO complex delineates the path for electron transfer and reveals a novel protein–protein interaction.
  32. [32]
    The Binding Interface of Cytochrome c and Cytochrome c1 in ... - NIH
    The interaction of cytochrome c with ubiquinol-cytochrome c oxidoreductase (bc1 complex) has been studied for >30 years, yet many aspects remain unclear or ...Missing: CcO | Show results with:CcO
  33. [33]
    Dynamic redox recycling of cytochrome c - ScienceDirect
    Applying this technique the diffusion coefficient of cytochrome c in buffered aqueous solution was determined to be 8.37 × 10−7 cm2 s−1. ... [2]. K.B. Oldham.
  34. [34]
    Electron transfer between cytochrome c and the isolated CuA domain
    May 2, 1995 · In low ionic strength medium, the domain oxidizes Paracoccus cytochrome c-550 and horse mitochondrial cytochrome c at the rates of 1.5 x 10(6) ...
  35. [35]
    Mitochondrial electron transport chain, ROS generation and ...
    May 8, 2019 · A total of four electrons at a time from cytochrome c are almost simultaneously transferred to bind dioxygen; eight protons in total are removed ...
  36. [36]
    Cytochrome c/cardiolipin relations in mitochondria: a kiss of death
    A mitochondria-specific phospholipid, cardiolipin (CL), interacts with cytochrome c (cyt c) to form a peroxidase complex that catalyzes CL oxidation.
  37. [37]
    Conformational properties of cardiolipin-bound cytochrome c - PNAS
    Dec 21, 2011 · Interactions of cytochrome c (cyt c) with cardiolipin (CL) are important for both electron transfer and apoptotic functions of this protein.
  38. [38]
    Cytochrome c in the apoptotic and antioxidant cascades - PubMed
    Feb 27, 1998 · (1) Cytochrome c released from the inner mitochondrial membrane to the intermembrane space can operate as an enzyme oxidizing O2.- back to O2.
  39. [39]
    The kinetics of the reduction of cytochrome c by the superoxide ...
    The second-order rate constant for the reaction of O2- with ferricytochrome c depends on the pH of the matrix solution, decreasing rapidly at pH greater than 8.
  40. [40]
  41. [41]
    The mitochondrial-targeted compound SS-31 re-energizes ischemic ...
    Jul 11, 2013 · In addition, the SS-31/cardiolipin complex inhibited cytochrome c peroxidase activity, which catalyzes cardiolipin peroxidation and results ...
  42. [42]
    VDAC regulation by the Bcl-2 family of proteins - Nature
    Dec 13, 2000 · Bax/Bak induces cytochrome c release through the VDAC​​ We have shown that VDAC activity is directly modulated by the Bcl-2 family of proteins:42 ...
  43. [43]
    Requirement of cytochrome c for apoptosis in human cells - Nature
    May 26, 2006 · We found that cytochrome c was required for apoptosis induced by both DNA damage and, unexpectedly, TNFα. Overall, this study established that ...
  44. [44]
    A Small Molecule that Induces Intrinsic Pathway Apoptosis with ...
    Dec 1, 2015 · Time-course analyses reveal Raptinal induces cytochrome c release and caspase activation within minutes (Figures 2A, 2B, S2A, and S2B).
  45. [45]
    Diverse functions of cytochrome c in cell death and disease - PMC
    The redox-active protein cytochrome c is a highly positively charged hemoglobin that regulates cell fate decisions of life and death.Cytochrome C Release Into... · Role Of Cytochrome C In... · Targeting Cytochrome C In...Missing: percentage | Show results with:percentage
  46. [46]
    Prevention of apoptosis by Bcl-2: release of cytochrome c ... - PubMed
    Overexpression of Bcl-2 prevents cells from undergoing apoptosis in response to a variety of stimuli. Cytosolic cytochrome c is necessary for the initiation of ...Missing: sequesters paper
  47. [47]
    The BCL2 family: from apoptosis mechanisms to new advances in ...
    Mar 21, 2025 · The B cell lymphoma 2 (BCL2) protein family critically controls apoptosis by regulating the release of cytochrome c from mitochondria.
  48. [48]
    XIAP inhibits caspase-3 and -7 using two binding sites - PubMed - NIH
    The X-linked inhibitor of apoptosis protein (XIAP) uses its second baculovirus IAP repeat domain (BIR2) to inhibit the apoptotic executioner caspase-3 and -7.Missing: seminal paper
  49. [49]
    IAP-family protein survivin inhibits caspase activity and apoptosis ...
    Survivin is a member of the inhibitor of apoptosis protein (IAP) family. We investigated the antiapoptotic mechanism of Survivin, as well as its expression ...Missing: paper | Show results with:paper
  50. [50]
    Hsp27 negatively regulates cell death by interacting with cytochrome c
    We show that the small HSP known as Hsp27 inhibits cytochrome-c-mediated activation of caspases in the cytosol. Hsp27 does not interfere with granzyme-B-induced ...
  51. [51]
    Sublethal cytochrome c release generates drug-tolerant persister cells
    Sep 1, 2022 · Our results reveal that sublethal cytochrome c release couples sublethal MOMP to caspase-independent initiation of an ATF4-dependent, drug-tolerant persister ...Missing: partial | Show results with:partial
  52. [52]
    Sublethal engagement of apoptotic pathways in residual cancer - NIH
    We review recent evidence that this sublethal MOMP drives the aggressive features of residual cancer cells while templating a host of unique vulnerabilities.
  53. [53]
    Tissue-specific regulation of cytochrome c by post-translational ...
    Horse heart Cytc has been shown to act as an H2O2 scavenger in rat heart mitochondria linked to reverse electron transfer from succinate to NAD+ involving ...Missing: melting temperature
  54. [54]
    Cytochrome c is rapidly reduced in the cytosol after mitochondrial ...
    Cytochrome c is rapidly reduced in the cytosol after mitochondrial outer membrane permeabilization ... less than 5%. Given the difficulty in quantifying ...
  55. [55]
    Constitutive presence of cytochrome c in the cytosol of a ... - PubMed
    Constitutive presence of cytochrome c in the cytosol of a chemoresistant leukemic cell line ... The release of cyt c in non-apoptotic K562/ADR cells was ...
  56. [56]
    Cytochrome c Is Released in a Reactive Oxygen Species ... - NIH
    In the former case, it was shown that the released cyt c (1) can work as a ROS scavenger and as an electron donor to cytochrome oxidase, thus driving ATP ...Missing: basal | Show results with:basal
  57. [57]
    Peroxidase Activity and Structural Transitions of Cytochrome c ...
    During apoptosis, cytochrome c (cyt c) is released from intermembrane space of mitochondria into the cytosol where it triggers caspase-dependent machinery.
  58. [58]
    Review Identifying the role of cytochrome c in post-resuscitation ...
    Cytochrome c, an electron carrier that normally resides in the mitochondrial intermembrane space, may translocate to the cytosol under ischemic and hypoxic ...The Cytochrome C · Cytochrome C And Programmed... · Cytochrome C And Cardiac...
  59. [59]
    Mitochondrial cytochrome c shot towards histone chaperone ...
    Thus, Cc may have a major regulatory role in DNA repair by fine‐tuning nucleosome assembly activity and likely nuclear condensate formation. Keywords: chromatin ...
  60. [60]
    Cytochrome c prompts the recruitment of its nuclear partners SET ...
    Aug 16, 2024 · Here, we show that SET/TAF-Iβ experiences phase separation together with respiratory cytochrome c (Cc), which translocates to the nucleus upon DNA damage.Missing: bioinformatics hotspots
  61. [61]
    Nuclear cytochrome c - a mitochondrial visitor regulating damaged ...
    Nuclear cytochrome c - a mitochondrial visitor regulating damaged chromatin dynamics ... DNA repair. If DNA damage persists or is exacerbated, the nuclear Cyt c ...
  62. [62]
    Cytochrome C-like Domain Within the Human BK Channel - PubMed
    Jul 22, 2025 · Large-conductance, voltage- and calcium-activated potassium (BK) channels are crucial regulators of cellular excitability, influenced by ...
  63. [63]
    Cytochrome c peroxidase (CcP) is a molecular determinant of the ...
    Jan 13, 2017 · Since bacterial CcPs reduce H2O2 to water, it has been proposed that they have a role in H2O2 scavenging and the response to oxidative stress.Materials And Methods · Results · Perr Regulator
  64. [64]
    Mapping cellular stress and lipid dysregulation in Alzheimer-related ...
    Nov 15, 2024 · Our study reveals nuclear condensation, indicating cellular degeneration, and increased levels of cytochrome c, showing mitochondrial dysfunction, in the ...
  65. [65]
    Tissue-specific regulation of cytochrome c by post-translational ...
    Sep 17, 2018 · Cyt c is tightly regulated by allosteric mechanisms, tissue-specific isoforms, and post-translational modifications (PTMs). Distinct residues ...
  66. [66]
    Cytochrome c lysine acetylation regulates cellular respiration and ...
    Jul 13, 2023 · We show that K39 acetylation and acetylmimetic K39Q replacement increases cytochrome c oxidase (COX) activity and ROS scavenging while inhibiting apoptosis.
  67. [67]
    Structural and functional insights into lysine acetylation of ... - PubMed
    Post-translational modifications frequently modulate protein functions. Lysine acetylation in particular plays a key role in interactions between ...
  68. [68]
    Differential Ubiquitin-dependent Degradation of the Yeast Apo ...
    We report herein that this degradation of apo-iso-1-cytochromec is dependent on ubiquitination and on the action of the proteasome.
  69. [69]
    PARC/CUL9 Mediates the Degradation of Mitochondrial-released ...
    We report that cytochrome c (cyt c), a key trigger of apoptosis that is released upon mitochondrial permeabilization, is targeted for proteasome-mediated ...
  70. [70]
    S-Nitrosylation: NO-Related Redox Signaling to Protect Against ...
    Under physiologic conditions, protein S>-nitrosylation and SNOs provide protection preventing further cellular oxidative and nitrosative stress.
  71. [71]
    An overview on glycation: molecular mechanisms, impact on ...
    Apr 12, 2024 · Glycation turns cytochrome c into an inducer of apoptosis (Sharma et al. 2019) and can also impair the enzymatic functions of high-density ...
  72. [72]
    Advanced glycation end products inhibit glucose-stimulated insulin ...
    Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine ...
  73. [73]
    Phosphorylations and Acetylations of Cytochrome c Control ... - MDPI
    Phosphorylations and acetylations of cytochrome c control mitochondrial respiration, mitochondrial membrane potential, energy, ROS, and apoptosis.Missing: percentage | Show results with:percentage
  74. [74]
    Cardiac Tyrosine 97 Phosphorylation of Cytochrome c Regulates ...
    Feb 4, 2025 · It was previously reported that tyrosine 97 (Y97) of cytochrome c is phosphorylated in cow heart tissue under physiological conditions.Missing: Tyr97 | Show results with:Tyr97
  75. [75]
    Oxidative stress is tightly regulated by cytochrome c phosphorylation ...
    Jul 17, 2018 · Oxidative stress is tightly regulated by cytochrome c phosphorylation and respirasome factors in mitochondria | PNAS.
  76. [76]
    Tyrosine 67 Phosphorylation Controls Respiration and Limits the ...
    We earlier reported that bovine heart Cytc is phosphorylated on Y97 [57]. Here we mapped a novel second phosphorylation site mapped to Y67 of Cytc purified ...Missing: Tyr97 | Show results with:Tyr97
  77. [77]
    Tyrosine 67 Phosphorylation Controls Respiration and Limits the ...
    Jun 21, 2025 · We here report the phosphorylation of Y67 of Cytc purified from bovine heart mapped by mass spectrometry. We characterized the functional ...Missing: Tyr97 | Show results with:Tyr97
  78. [78]
    Phosphorylation disrupts long-distance electron transport in ... - Nature
    Nov 19, 2022 · Cytochrome c is thought to adjust its activity by changing the affinity for its partners via Tyr48 phosphorylation, but it is unknown how it ...
  79. [79]
    Chapter X. Phosphorylation of mammalian cytochrome c and ...
    This chapter focuses on the latter and discusses all mapped phosphorylation sites based on the crystal structures of COX and Cytc.
  80. [80]
    Control of mitochondrial electron transport chain flux and apoptosis
    Cytochrome c (Cytc)1is a cellular life and death decision molecule that regulates cellular energy supply and apoptosis through tissue specific post- ...
  81. [81]
    Amino-acid sequence of horse heart cytochrome c - PubMed
    Amino-acid sequence of horse heart cytochrome c. Nature. 1961 Dec 23:192:1125-7. doi: 10.1038/1921125a0. Authors. E MARGOLIASH, E L SMITH, G KREIL, H TUPPY.Missing: first determination<|control11|><|separator|>
  82. [82]
    PRIMARY STRUCTURE AND EVOLUTION OF CYTOCHROME C
    Two areas of the amino acid sequence remain invariant. The first, extending from residues 17 to 21, immediately follows the heme attachment; it contains one of ...
  83. [83]
    Redox titrations of cytochrome c oxidase. An analysis of a multi ...
    Equilibrium redox titrations of cytochrome c oxidase available in the literature are discussed in terms of models with interactions both with respect to ...
  84. [84]
    Methods for Detection of Mitochondrial and Cellular Reactive ... - NIH
    Superoxide detection by cytochrome c. Ferricytochrome c reduction is a time-honored and accurate method for detecting large amounts of O2•− released by ...Missing: ΔA550 | Show results with:ΔA550
  85. [85]
    Rapid microplate assay for superoxide scavenging efficiency
    Here we report a method to determine superoxide scavenging efficiency, using kinetic analysis of cytochrome c reduction and an automated UV/vis microtiter ...Missing: detection ΔA550
  86. [86]
    Cytochrome c as a Peroxidase: Activation of the Precatalytic Native ...
    Nov 8, 2017 · This is the first report that identifies H 2 O 2 -induced covalent modifications as an essential component for the peroxidase activity of native cyt c.
  87. [87]
    Peroxidase Activity and Structural Transitions of Cytochrome c ...
    We discovered that cyt c plays another critical role in early apoptosis as a cardiolipin (CL)-specific oxygenase to produce CL hydroperoxides required for ...
  88. [88]
    Immobilization of cytochrome c and its application as ...
    Jan 1, 2018 · Biosensors based on Cyt c have extensive potential application in the determination of hydrogen peroxide, superoxide anion radical, nitric oxide ...
  89. [89]
    Immobilization of cytochrome c and its application as ... - PubMed
    Jan 1, 2018 · Cyt c immobilization techniques, including physical adsorption, entrapment in hydrogel or polymers, layer-by-layer assembly, Langmuir-Blodgett, and covalent ...
  90. [90]
    A cytochrome c mutant with high electron transfer and antioxidant ...
    A cytochrome c mutant lacking apoptogenic function but competent in electron transfer and antioxidant activities has been constructed.
  91. [91]
    Insights into Interprotein Electron Transfer of Human Cytochrome c ...
    Dec 1, 2016 · ... molecular contacts observed in the crystal structure of human cyt c (PDB 3ZCF), which contains four molecules in the unit cell. (53) ...
  92. [92]
    High-resolution three-dimensional structure of horse heart ... - PubMed
    Jul 20, 1990 · A resolution three-dimensional structure of oxidized horse heart cytochrome c has been elucidated and refined to a final R-factor of 0.17.Missing: determination | Show results with:determination
  93. [93]
    Entry - *123970 - CYTOCHROME C, SOMATIC; CYCS - OMIM
    Cytochrome c is located in the mitochondria of all aerobic cells and is involved in the electron transport system that functions in oxidative phosphorylation.Missing: isoforms | Show results with:isoforms
  94. [94]
    Mutations of cytochrome c identified in patients with ...
    In this family, the thrombocytopenia is caused by the G41S mutation of the somatic isoform of the cytochrome c (CYCS) gene, the only naturally occurring ...
  95. [95]
    Six novel families with mutations of the cytochrome c gene - PubMed
    THC4 is an autosomal-dominant thrombocytopenia caused by mutations in CYCS, the gene encoding cytochrome c (CYCS), a small haeme protein essential for electron ...
  96. [96]
    Role of cytochrome c in α-synuclein radical formation: implications of ...
    Nov 24, 2016 · Mitochondrial dysfunction during PD pathogenesis leads to release of cytochrome c in the cytosol. Once in the cytosol, cytochrome c has one of ...
  97. [97]
    Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease
    A deficiency of cytochrome c oxidase is the most common defect in the mitochondrial electron transport chain (ETC) in AD, leading to an increase in ROS ...
  98. [98]
    (PDF) Cardiac Tyrosine 97 Phosphorylation of Cytochrome c ...
    Feb 4, 2025 · Tyrosine 67 Phosphorylation Controls Respiration and Limits the Apoptotic Functions of Cytochrome c. June 2025 · Cells. Junmei Wan ...<|control11|><|separator|>
  99. [99]
    An Innovative Mitochondrial-targeted Gene Therapy for Cancer ...
    Mar 27, 2024 · However, these therapies typically target specific signaling pathways or proteins, such as hexokinase (13), Bcl-2 family proteins (14), thiol ...
  100. [100]
    Targeting apoptosis in cancer therapy - PMC - PubMed Central - NIH
    Release of cytochrome c from the mitochondria is positively regulated by the proapoptotic BCL-2 family members such as BAX (BCL-2-associated X protein), BAK ( ...
  101. [101]
    Anticancer Nanoparticle Carriers of the Proapoptotic Protein ... - MDPI
    Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells. Exp. Ther. Med. 2013, 6, 786–790 ...
  102. [102]
    Small molecule OPA1 inhibitors amplify cytochrome c release and ...
    Jul 4, 2025 · MYLS22 enhanced proapoptotic cytochrome c release and sensitized breast adenocarcinoma cells to anti–Bcl-2 therapy, without toxicity on noncancer cells.
  103. [103]
    Circulating Cytochrome c as Potential Biomarker of Impaired ...
    Nov 15, 2010 · Serum cytochrome c is detectable in the early phase of STEMI treated with pPCI and is associated with clinical signs of impaired myocardial reperfusion.
  104. [104]
    Diagnostic and Prognostic Utility of Circulating Cytochrome c ... - NIH
    We show that detection of circulating cytochrome c, a marker for mitochondrial damage, was associated with increased in-hospital mortality.